Melanoma during Ruxolitinib Treatment for Myelofibrosis by Lingzhi Zhong, Houmin Li, Guangdong Wen

Subjects: Get full text

Evaluation of the Effects of Baricitinib and Ruxolitinib in Acute Respiratory Distress Syndrome (ARDS) Patients: A Meta-Analysis Study by Mehdi Nurmohammad Ahari, Ata Mahmoodpoor, Hassan Soleimanpour, Hamed Valizadeh, Shadi Ziaie, Hadi Hamishehkar

Subjects: Get full text

Ruxolitinib Has a Protective Effect on Ovarian and Endometrial Tissues in Diabetic Rats via STAT3 Pathway by Savaş Özdemir, Fatih Şahin, Oytun Erbaş

Subjects: Get full text

Retrospective analysis of ruxolitinib as induction treatment in pediatric hemophagocytic lymphohistiocytosis by Shu-yi Guo, Jun-yan Han, Kun-yin Qiu, Jian Wang, Jian-pei Fang, Dun-hua Zhou

Subjects: “…Ruxolitinib…”
Get full text

Acute graft versus host disease postliver transplant with mucocutaneous manifestations and pancytopenia: Remission with Janus kinase inhibitor by Roy Mendoza, BS, Louisa Liu, MD, Amylee Sam, MD, Hisham Abdel-Azim, MD, Michael Greas, MD, Harry Dao, MD

Subjects: Get full text

Application of inhibitor JAK1 and JAK2 ruxolitinib as pre- and posttransplant therapy in patients with myelofibrosis by M. V. Barabanshchikova, E. V. Morozova, Yu. Yu. Vlasova, V. V. Baykov, L. S. Zubarovskaya, B. V. Afanasyev

Subjects: Get full text

JAK/STAT inhibition protects glucocorticoid receptor knockout mice from lethal malaria-induced hypoglycemia and hyperinflammation by Fran Prenen, Leen Vandermosten, Sofie Knoops, Emilie Pollenus, Hendrik Possemiers, Pauline Dagneau de Richecour, Giorgio Caratti, Christopher Cawthorne, Sabine Vettorazzi, Yevva Cranshoff, Dominique Schols, Sandra Claes, Christophe M Deroose, Uwe Himmelreich, Jan Tuckermann, Philippe E Van den Steen

Subjects: Get full text

Cord blood T regulatory cells synergize with ruxolitinib to improve GVHD outcomes by Ke Zeng, Hongbing Ma, Meixian Huang, Mi-Ae Lyu, Tara Sadeghi, Christopher R. Flowers, Simrit Parmar

Subjects: Get full text

Ruxolitinib as a treatment strategy for SARS-CoV-2 pneumonia: clinical experience in a real-world setting by Roberto Ovilla-Martinez, Xochitl Cota-Rangel, Jose De La Peña-Celaya, Mariana Alejandra Alvarado-Zepeda, Alejandro Jiménez Sastré, Humberto Azuara Forcelledo, Bernardino Ordoñez Rodriguez, Juan Pulido Broca, Aaron Molina Jaimes, Alejandro Muñiz-Carvajal, Maria Magdalena Bahena García, Eduardo Cervera Ceballos, Nidia Paulina Zapata Canto, Jorge Oscar García Mendez, Omar Noel García Jímenez, Jesus Alberto Salas Heredia, Javier Solis Soto, Ruben Alberto Villalobos Mendez, Gregorio Ignacio Ibarra, Cindy Ledesma de la Cruz, Nora Araujo Martinez, Jessi Juárez Lara, Cecilio Omar Ceballos Zuñiga, Felipe Vicente Villaseñor Pérez, Jose Carlos Herrera Garcia, Patricia Nuche Salazar, Alfredo Dominguez Paregrina, Bertha Arizpe Bravo, Gabriela Enciso Figueroa, Teresita Trujillo, Adriana Miguel Álvarez, Diego de Jesús García Gallegos, Alejandro Ortiz Arroyo, Claudia Ivette Solorzano Soto, Hiram Javier Jaramillo Ramírez, Ibis De la Cruz Hernández, Sergio De Gante Martínez, Guadalupe Esmeralda Montesinos Gómez, Silvia Martínez Velasco, Roberto García Graullera, Miguel Angel Vázquez López, Victor Itaí Urbalejo Ceniceros, Yolanda Lugo García, Ana Itamar González Ávila, Jorge Duque Rodriguez, Rodolfo Ruiz Luján, Violeta I. Rodríguez Rivera, Lucio Soberanes Ramírez, Pamela Elena Baez-Islas

Subjects: Get full text

Durable response to venetoclax, azacytidine, and ruxolitinib in chronic-phase myelofibrosis resistant to ruxolitinib: a case report and literature review by Xiaohong Liu, Xiujuan Zhang, Hongxia Shi

Subjects: Get full text

Treatment Strategies Used in Treating Myelofibrosis: State of the Art by Massimo Martino, Martina Pitea, Annalisa Sgarlata, Ilaria Maria Delfino, Francesca Cogliandro, Anna Scopelliti, Violetta Marafioti, Simona Polimeni, Gaetana Porto, Giorgia Policastro, Giovanna Utano, Maria Pellicano, Giovanni Leanza, Caterina Alati

Subjects: Get full text

Ruxolitinib stopped before transplantation does not induce cytokine release in myelofibrosis by Sara Villar, Emmanuel Curis, Marie-Hélène Schlageter, Nelly Bosselut, Amandine Charbonnier, Marie-Thérèse Rubio, Pascal Turlure, Hélène Labussière, Jacques-Olivier Bay, Jérome Cornillon, Laure Vincent, Corentin Orvain, Jean-Jacques Kiladjian, David Michonneau, Gérard Socié, Marie Robin

Subjects: Get full text

Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis by MV Barabanshchikova, EV Morozova, VV Baikov, IM Barkhatov, NN Mamaev, SN Bondarenko, AL Alyanskii, LS Zubarovskaya, BV Afanas’ev

Subjects: Get full text

Ruxolitinib-dependent reduction of seizure load and duration is accompanied by spatial memory improvement in the rat pilocarpine model of temporal lobe epilepsy by Andrew Carrel, Eleonora Napoli, Kathryn Hixson, Jessica Carlsen, Yasmin Cruz Del Angel, Dana Strode, Nicolas Busquet, Vijay Kumar, Michael F. Wempe, Shelley J. Russek, Amy R. Brooks-Kayal

Subjects: Get full text

Oncolytic vesicular stomatitis virus alone or in combination with JAK inhibitors is effective against ovarian cancer by Karen Geoffroy, Victor Mullins-Dansereau, Kim Leclerc-Desaulniers, Mélissa Viens, Marie-Claude Bourgeois-Daigneault

Subjects: Get full text

Development and Evaluation of Bilayer Sustained-Release Tablets of Ruxolitinib Using Discriminative Pharmacokinetic Analysis and IVIVC by Namhyuck Kim, Kyoungho Kim, Seungwei Jeong, Jiyeong Kim, Helen Cho, Young-Joo Lee, Sangyeob Park

Subjects: Get full text

Weight gain secondary to the use of oral Janus kinase inhibitors: A systematic review and meta-analysis by Grace Xiong, BHSc, Eric Yu, Martin Heung, Jaehyeong Yang, BSc, Megan Lowe, MPH, Mohannad Abu-Hilal, MD

Subjects: Get full text

Combination therapy with ruxolitinib plus low-dose cytarabine or mercaptopurine in patients with blast-phase myelofibrosis by M. S. Fominykh, V. A. Shuvaev, I. S. Martynkevich, L. B. Polushkina, V. Yu. Udal’eva, K. M. Abdulkadyrov

Subjects: Get full text

Efficacy and safety of oral upadacitinib-topical ruxolitinib combination therapy in the treatment of progressive nonsegmental vitiligo by Weiran Li, MD, Jinping Gao, MD, He Huang, MD, Tingting Zhu, MD, Xianfa Tang, MD, Ruochen Zhang, MM, Xiaojian Chen, MM, Yang Wang, BS, Yaohua Zhang, MD, PhD, Xuejun Zhang, MD, PhD, Yong Cui, MD, PhD, Youwen Zhou, MD, PhD, Bo Zhang, MD, PhD

Subjects: Get full text

JAK2 Inhibitors and Emerging Therapies in Graft-Versus-Host Disease: Current Perspectives and Future Directions by Behzad Amoozgar, Ayrton Bangolo, Abdifitah Mohamed, Charlene Mansour, Daniel Elias, Christina Cho, Siddhartha Reddy

Subjects: Get full text